NIH-funded research R03 grant

Modifying BMP9 signaling to improve secondary lymphedema

Official title: Modifying bone morphogenetic protein 9 (BMP9) signaling in secondary lymphedema

Funded at Brigham and Women's Hospital · NIH-11286438 · Data updated 2026-11-12

A patient-focused project aims to understand how BMP9 signaling affects lymphatic health after surgery and whether boosting BMP9 could help reduce swelling and improve function.

Quick facts

Grant typeR03 grant
Study typeNIH-funded research
Funding institutionBrigham and Women's Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startAugust 1, 2026
Project endJuly 31, 2028
Funding year2026
Award (this year)$151,950
NIH project number1R03AR086904-01
Project IDNIH-11286438 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are individuals with secondary lymphedema or patients who have undergone surgical lymphatic disruption and are eligible for research on lymphatic regeneration.

Less likely to help

Patients with unrelated conditions or those unable to participate in preclinical model studies may not benefit.

What this research studies

Secondary lymphedema severely impacts daily life for millions by causing persistent swelling, pain, and wounds after lymphatic disruption. The research will look at how changing BMP9 signaling changes lymphatic growth and function after surgical injury in animal models to reflect human biology. It also tests two approaches to modulate BMP9: adding BMP9 protein to boost signaling and blocking an inhibitor to sustain BMP9 activity, with the goal of improving lymphatic regeneration. This work could lead to better animal models and new directions for therapies in people with lymphedema.

Why it matters

Potential benefit: If successful, this work could guide new treatments that improve lymphatic function and quality of life for people with secondary lymphedema.

How similar studies have gone: Earlier work shows that signaling pathways can influence lymphatic growth; this proposal builds on that by testing BMP9-specific strategies in regeneration models.

Where this research is happening

  • Brigham and Women's Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: Agarwal, Shailesh — Brigham and Women's Hospital
  • Study coordinator: Agarwal, Shailesh

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.